Search

Fenn C. Mathew

Supervisory Patent Examiner (ID: 8626, Phone: (571)272-4978 , Office: P/3781 )

Most Active Art Unit
3764
Art Unit(s)
3764, OPET, 3733, 4172, 3781
Total Applications
843
Issued Applications
446
Pending Applications
28
Abandoned Applications
370

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1524172 [patent_doc_number] => 06353024 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-05 [patent_title] => 'Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine' [patent_app_type] => B1 [patent_app_number] => 09/490093 [patent_app_country] => US [patent_app_date] => 2000-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 9969 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/353/06353024.pdf [firstpage_image] =>[orig_patent_app_number] => 09490093 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/490093
Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine Jan 23, 2000 Issued
Array ( [id] => 4326162 [patent_doc_number] => 06329339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity' [patent_app_type] => 1 [patent_app_number] => 9/423611 [patent_app_country] => US [patent_app_date] => 2000-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2470 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/329/06329339.pdf [firstpage_image] =>[orig_patent_app_number] => 423611 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/423611
Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity Jan 17, 2000 Issued
Array ( [id] => 4304851 [patent_doc_number] => 06187791 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Method of providing an antihistaminic effect in a hepatically impaired patient' [patent_app_type] => 1 [patent_app_number] => 9/481404 [patent_app_country] => US [patent_app_date] => 2000-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1784 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187791.pdf [firstpage_image] =>[orig_patent_app_number] => 481404 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/481404
Method of providing an antihistaminic effect in a hepatically impaired patient Jan 11, 2000 Issued
Array ( [id] => 4416798 [patent_doc_number] => 06177077 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-23 [patent_title] => 'TNT inhibitors for the treatment of neurological disorders' [patent_app_type] => 1 [patent_app_number] => 9/476643 [patent_app_country] => US [patent_app_date] => 1999-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6111 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/177/06177077.pdf [firstpage_image] =>[orig_patent_app_number] => 476643 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/476643
TNT inhibitors for the treatment of neurological disorders Dec 30, 1999 Issued
Array ( [id] => 4371352 [patent_doc_number] => 06288089 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Use of kinase inhibitors for treating neurodegenerative diseases' [patent_app_type] => 1 [patent_app_number] => 9/469980 [patent_app_country] => US [patent_app_date] => 1999-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16932 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 1313 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288089.pdf [firstpage_image] =>[orig_patent_app_number] => 469980 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/469980
Use of kinase inhibitors for treating neurodegenerative diseases Dec 20, 1999 Issued
Array ( [id] => 4353914 [patent_doc_number] => 06291527 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-18 [patent_title] => 'Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application' [patent_app_type] => 1 [patent_app_number] => 9/445672 [patent_app_country] => US [patent_app_date] => 1999-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6108 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/291/06291527.pdf [firstpage_image] =>[orig_patent_app_number] => 445672 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/445672
Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application Dec 9, 1999 Issued
Array ( [id] => 4329474 [patent_doc_number] => 06319953 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-20 [patent_title] => 'Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist' [patent_app_type] => 1 [patent_app_number] => 9/457241 [patent_app_country] => US [patent_app_date] => 1999-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19662 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/319/06319953.pdf [firstpage_image] =>[orig_patent_app_number] => 457241 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/457241
Treatment of depression and anxiety with fluoxetine and an NK-1 receptor antagonist Dec 7, 1999 Issued
60/304199 NOVEL METHODS AND COMPOSITIONS INVOLVING OPIOIDS AND ANTAGONISTS THEREOF Nov 28, 1999 Pending
Array ( [id] => 1566894 [patent_doc_number] => 06376513 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-23 [patent_title] => 'Drug for relieving pain and promoting the removal of calculi in urolithiasis' [patent_app_type] => B1 [patent_app_number] => 09/448422 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2226 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/376/06376513.pdf [firstpage_image] =>[orig_patent_app_number] => 09448422 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/448422
Drug for relieving pain and promoting the removal of calculi in urolithiasis Nov 23, 1999 Issued
Array ( [id] => 1533197 [patent_doc_number] => 06410560 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Drug for relieving pain and promoting the removal of calculi in urolithiasis' [patent_app_type] => B1 [patent_app_number] => 09/448423 [patent_app_country] => US [patent_app_date] => 1999-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 2227 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410560.pdf [firstpage_image] =>[orig_patent_app_number] => 09448423 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/448423
Drug for relieving pain and promoting the removal of calculi in urolithiasis Nov 23, 1999 Issued
Array ( [id] => 6064240 [patent_doc_number] => 20020032219 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-14 [patent_title] => 'USE OF ALPHA-1C SPECIFIC COMPOUNDS TO TREAT BENIGN PROSTATIC HYPERPLASIA' [patent_app_type] => new [patent_app_number] => 09/444783 [patent_app_country] => US [patent_app_date] => 1999-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11241 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20020032219.pdf [firstpage_image] =>[orig_patent_app_number] => 09444783 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/444783
Use of 1C specific compounds to treat benign prostatic hyperplasia Nov 21, 1999 Issued
Array ( [id] => 4171372 [patent_doc_number] => 06140335 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase' [patent_app_type] => 1 [patent_app_number] => 9/403005 [patent_app_country] => US [patent_app_date] => 1999-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1402 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140335.pdf [firstpage_image] =>[orig_patent_app_number] => 403005 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/403005
Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase Nov 18, 1999 Issued
Array ( [id] => 4356453 [patent_doc_number] => 06200983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-13 [patent_title] => 'Dosage forms containing apomorphine for ameliorating male erectile dysfunction' [patent_app_type] => 1 [patent_app_number] => 9/440451 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11091 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/200/06200983.pdf [firstpage_image] =>[orig_patent_app_number] => 440451 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/440451
Dosage forms containing apomorphine for ameliorating male erectile dysfunction Nov 14, 1999 Issued
Array ( [id] => 1475036 [patent_doc_number] => 06387907 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Use of serotonin agonists to alleviate disordered breathing episodes in a mammal' [patent_app_type] => B1 [patent_app_number] => 09/439799 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 26 [patent_no_of_words] => 11913 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387907.pdf [firstpage_image] =>[orig_patent_app_number] => 09439799 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/439799
Use of serotonin agonists to alleviate disordered breathing episodes in a mammal Nov 11, 1999 Issued
Array ( [id] => 1560459 [patent_doc_number] => 06436997 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-20 [patent_title] => 'Endogenous nitric oxide synthesis under conditions of low oxygen tension' [patent_app_type] => B1 [patent_app_number] => 09/429020 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 11525 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/436/06436997.pdf [firstpage_image] =>[orig_patent_app_number] => 09429020 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/429020
Endogenous nitric oxide synthesis under conditions of low oxygen tension Oct 28, 1999 Issued
Array ( [id] => 4320780 [patent_doc_number] => 06328997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-11 [patent_title] => 'Aqueous metal bicarbonate solution and method of use' [patent_app_type] => 1 [patent_app_number] => 9/422645 [patent_app_country] => US [patent_app_date] => 1999-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 26551 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/328/06328997.pdf [firstpage_image] =>[orig_patent_app_number] => 422645 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/422645
Aqueous metal bicarbonate solution and method of use Oct 21, 1999 Issued
09/425229 OMEGA-CARBOXY ARYL SUDSTITUTED DIPHENYL UREAS AS P38 KINASE INHIBITORS Oct 21, 1999 Abandoned
Array ( [id] => 4380744 [patent_doc_number] => 06303645 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Benzimidazole derivatives as modulators of IgE' [patent_app_type] => 1 [patent_app_number] => 9/422397 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6020 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303645.pdf [firstpage_image] =>[orig_patent_app_number] => 422397 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/422397
Benzimidazole derivatives as modulators of IgE Oct 20, 1999 Issued
Array ( [id] => 4206682 [patent_doc_number] => 06077869 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-20 [patent_title] => 'Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation' [patent_app_type] => 1 [patent_app_number] => 9/421566 [patent_app_country] => US [patent_app_date] => 1999-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2261 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/077/06077869.pdf [firstpage_image] =>[orig_patent_app_number] => 421566 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/421566
Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation Oct 19, 1999 Issued
Array ( [id] => 4260164 [patent_doc_number] => 06204245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-20 [patent_title] => 'Treatment of narcolepsy with immunosuppressants' [patent_app_type] => 1 [patent_app_number] => 9/398260 [patent_app_country] => US [patent_app_date] => 1999-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 9 [patent_no_of_words] => 10762 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/204/06204245.pdf [firstpage_image] =>[orig_patent_app_number] => 398260 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/398260
Treatment of narcolepsy with immunosuppressants Sep 16, 1999 Issued
Menu